Yoichi Inada

654 total citations
34 papers, 548 citations indexed

About

Yoichi Inada is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Yoichi Inada has authored 34 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 7 papers in Oncology. Recurrent topics in Yoichi Inada's work include Receptor Mechanisms and Signaling (5 papers), CAR-T cell therapy research (4 papers) and Renin-Angiotensin System Studies (4 papers). Yoichi Inada is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), CAR-T cell therapy research (4 papers) and Renin-Angiotensin System Studies (4 papers). Yoichi Inada collaborates with scholars based in Japan and United States. Yoichi Inada's co-authors include Yoshinobu Yamazaki, Nobuo Shibata, Shigeru Nakano, Kazuyasu Maruyama, Junji Kuroda, Toru Tamura, Tatsuya Nagasawa, Hiroshi Kusama, Shigetoshi Chiba and Tokio Nakane and has published in prestigious journals such as Blood, Applied Physics Letters and Biochemical and Biophysical Research Communications.

In The Last Decade

Yoichi Inada

30 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoichi Inada Japan 12 236 232 104 95 93 34 548
Liu Yl China 9 282 1.2× 402 1.7× 169 1.6× 36 0.4× 175 1.9× 30 785
Masashi Miyao Japan 10 161 0.7× 198 0.9× 47 0.5× 22 0.2× 135 1.5× 24 517
Emma Proïcs France 6 356 1.5× 319 1.4× 35 0.3× 62 0.7× 34 0.4× 7 666
M Granzow Germany 12 182 0.8× 442 1.9× 60 0.6× 32 0.3× 449 4.8× 13 760
Ludovica Ceci Italy 14 130 0.6× 226 1.0× 38 0.4× 62 0.7× 159 1.7× 33 537
Star Seyedkazemi United States 8 82 0.3× 495 2.1× 171 1.6× 55 0.6× 296 3.2× 12 705
Vincent Kaddai France 12 323 1.4× 214 0.9× 53 0.5× 11 0.1× 126 1.4× 15 650
H. Cao Canada 11 176 0.7× 45 0.2× 63 0.6× 30 0.3× 24 0.3× 20 395
H Shimizu Japan 10 100 0.4× 248 1.1× 41 0.4× 27 0.3× 142 1.5× 20 487
Annie J. Kruger United States 12 89 0.4× 181 0.8× 53 0.5× 78 0.8× 117 1.3× 20 422

Countries citing papers authored by Yoichi Inada

Since Specialization
Citations

This map shows the geographic impact of Yoichi Inada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichi Inada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichi Inada more than expected).

Fields of papers citing papers by Yoichi Inada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoichi Inada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichi Inada. The network helps show where Yoichi Inada may publish in the future.

Co-authorship network of co-authors of Yoichi Inada

This figure shows the co-authorship network connecting the top 25 collaborators of Yoichi Inada. A scholar is included among the top collaborators of Yoichi Inada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoichi Inada. Yoichi Inada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naito, Yoichi, Nozomu Fuse, Masashi Wakabayashi, et al.. (2025). Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr). Frontiers in Oncology. 15. 1633324–1633324.
2.
Hasegawa, Aiko, Shoji Saito, Shigeru Nakano, et al.. (2021). Mutated GM‐CSF‐based CAR‐T cells targeting CD116/CD131 complexes exhibit enhanced anti‐tumor effects against acute myeloid leukaemia. Clinical & Translational Immunology. 10(5). e1282–e1282. 21 indexed citations
3.
4.
Tomiyama, Yoshitaka, et al.. (2007). Expressions and mechanical functions of α1-adrenoceptor subtypes in hamster ureter. European Journal of Pharmacology. 573(1-3). 201–205. 19 indexed citations
5.
Ogawa, Shinichiro, Yoichi Inada, Akiko Kamiyoshi, et al.. (2006). CHARACTERIZATION OF CYTOCHROME P450 EXPRESSION IN MURINE EMBRYONIC STEM CELL-DERIVED HEPATIC TISSUE SYSTEM. Drug Metabolism and Disposition. 34(4). 696–701. 28 indexed citations
6.
Nagasawa, Tatsuya, Yoichi Inada, Shigeru Nakano, et al.. (2006). Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet. European Journal of Pharmacology. 536(1-2). 182–191. 199 indexed citations
7.
Nakano, Shigeru, Yoichi Inada, Hiroaki Masuzaki, et al.. (2006). Bezafibrate regulates the expression and enzyme activity of 11β-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes. American Journal of Physiology-Endocrinology and Metabolism. 292(4). E1213–E1222. 32 indexed citations
8.
Imamura, Keiko, Yoshihide Kanemaki, Joji Okamoto, et al.. (2004). . Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 13(2). 143–148. 2 indexed citations
9.
Shoda, Junichi, Yoichi Inada, Atsutoshi Tsuji, et al.. (2004). Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARα-mediated redistribution of ABCB4. Journal of Lipid Research. 45(10). 1813–1825. 51 indexed citations
10.
Nakane, Tokio, Toshio Satoh, Yoichi Inada, et al.. (2004). Molecular cloning and expression of HRLRRP, a novel heart-restricted leucine-rich repeat protein. Biochemical and Biophysical Research Communications. 314(4). 1086–1092. 13 indexed citations
11.
Inada, Yoichi, Tokio Nakane, & Shigetoshi Chiba. (2003). Relationship between ligand binding and YIPP motif in the C-terminal region of human AT1 receptor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1640(1). 33–41. 4 indexed citations
12.
Nakane, Tokio, et al.. (2002). Heterogeneous Distribution Of β‐Adrenoceptors and Muscarinic Receptors In The Sinoatrial Node And Right Atrium Of The Dog. Clinical and Experimental Pharmacology and Physiology. 29(8). 666–672. 6 indexed citations
13.
Inada, Yoichi, Tokio Nakane, & Shigetoshi Chiba. (2002). Binding of KRH‐594, an antagonist of the angiotensin II type 1 receptor, to cloned human and rat angiotensin II receptors. Fundamental and Clinical Pharmacology. 16(4). 317–323. 8 indexed citations
14.
Inada, Yoichi, Shigeki Tazawa, Makoto Murakami, & Masuo Akahane. (2001). KRH‐594, A New Angiotensin At1 Receptor Antagonist, Prevents End‐Organ Damage In Stroke‐Prone Spontaneously Hypertensive/Izm Rats. Clinical and Experimental Pharmacology and Physiology. 28(3). 206–211. 9 indexed citations
15.
Inada, Yoichi, et al.. (2001). Effects of dopamine d2 receptor agonists in a pituitary transplantation‐induced hyperprolactinaemia/anovulation model in rats. Clinical and Experimental Pharmacology and Physiology. 28(8). 651–658. 13 indexed citations
16.
Nakane, Tokio, Yoichi Inada, Fumiaki Itoh, & Shigetoshi Chiba. (2000). Rat homologue of the human Mr 110 000 antigen is the protein that expresses widely in various tissues. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1493(3). 378–382. 4 indexed citations
17.
Inada, Yoichi, Makoto Murakami, Shigeki Tazawa, & Masuo Akahane. (2000). Krh‐594, A New Angiotensin At1 Receptor Antagonist, Ameliorates Nephropathy And Hyperlipidaemia In Diabetic Spontaneously Hypertensive Rats. Clinical and Experimental Pharmacology and Physiology. 27(4). 270–276. 8 indexed citations
18.
Inada, Yoichi, et al.. (1999). New hyperprolactinemia and anovulation model in common marmoset (Callithrix jacchus) and effect of cabergoline. European Journal of Pharmacology. 368(1). 57–66. 11 indexed citations
19.
Inada, Yoichi, Hideaki Watanabe, Kazuko Ohgi, & Masachika IRIE. (1991). Isolation, Characterization, and Primary Structure of a Base Non-Specific and Adenylic Acid Preferential Ribonuclease with Higher Specific Activity from Trickoderma viride. The Journal of Biochemistry. 110(6). 896–904. 15 indexed citations
20.
Imai, Yukimichi, et al.. (1984). . Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 21(2). 107–114.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liu Yl Breakdown of academic impact, for papers by Masashi Miyao Breakdown of academic impact, for papers by Emma Proïcs Breakdown of academic impact, for papers by M Granzow Breakdown of academic impact, for papers by Ludovica Ceci Breakdown of academic impact, for papers by Star Seyedkazemi Breakdown of academic impact, for papers by Vincent Kaddai Breakdown of academic impact, for papers by H. Cao Breakdown of academic impact, for papers by H Shimizu Breakdown of academic impact, for papers by Annie J. Kruger
Rankless by CCL
2026